2026 Q2 Portfolio Activity
In 2026 Q2, ARMISTICE CAPITAL, LLC maintained a portfolio of 433 distinct positions. The most significant new addition was WATERS CORP, now representing 0.34% of the total fund value. They heavily accumulated shares in ISHARES TR, increasing the position by 65.7%. The fund also reduced its exposure to TRAVERE THERAPEUTICS INC by 89.8%.
Position History
hover any row below to update
Loading…
Total Positions
433
Quarter
2026 Q2
Top Holding
SPY (29.2%)
Top 10 Concentration
61.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 433
ARMISTICE CAPITAL, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPY
PUT
STATE STR SPDR ...
|
PUT Option | 29.24% | 24.28% |
#1
Prev: #1
|
9.0 |
—
|
1,100,000 | 52.4% |
P
S
|
3,200,000 | $2,389,664,000 |
$409.05
+89.8%
|
2014 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
IWM
PUT
ISHARES TR
|
PUT Option | 21.32% | 15.43% |
#2
Prev: #2
|
8.5 |
—
|
2,300,000 | 65.7% |
P
S
|
5,800,000 | $1,742,610,000 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.89% | 2.46% |
#3
2
Prev: #5
|
3.8 |
—
|
23,417 | 8.9% |
P
S
|
288,000 | $154,641,600 | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 1.59% | 1.99% |
#4
2
Prev: #6
|
1.6 |
—
|
-170,000 | -10.0% |
P
S
|
1,530,000 | $130,340,700 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 1.51% | 1.74% |
#5
3
Prev: #8
|
3.6 |
—
|
750,854 | 39.6% |
P
S
|
2,646,201 | $123,074,809 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 1.28% | 1.92% |
#6
1
Prev: #7
|
1.0 |
—
|
-390,000 | -12.2% |
P
S
|
2,810,000 | $104,279,100 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 1.25% | 0.90% |
#7
10
Prev: #17
|
3.5 |
—
|
436,804 | 57.1% |
P
S
|
1,201,342 | $102,342,325 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INCY
INCYTE CORP
|
Healthcare | 1.25% | 1.10% |
#8
5
Prev: #13
|
3.0 |
—
|
243,188 | 37.0% |
P
S
|
900,005 | $102,024,567 | 2017 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.10% | 1.70% |
#9
Prev: #9
|
0.4 |
—
|
-188,162 | -26.0% |
P
S
|
535,838 | $90,307,457 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 1.09% | 2.59% |
#10
7
Prev: #3
|
0.4 |
—
|
-3,324,878 | -67.9% |
P
S
|
1,572,539 | $89,335,941 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.09% | 1.63% |
#11
1
Prev: #10
|
0.9 |
—
|
-316,000 | -11.6% |
P
S
|
2,400,000 | $89,064,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.07% | 2.51% |
#12
8
Prev: #4
|
0.4 |
—
|
-1,003,054 | -48.4% |
P
S
|
1,071,395 | $87,393,690 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 0.93% | 0.71% |
#13
9
Prev: #22
|
2.9 |
—
|
35,000 | 23.6% |
P
S
|
183,000 | $76,060,290 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FRPT
FRESHPET INC
|
Consumer Defensive | 0.91% | 1.15% |
#14
2
Prev: #12
|
2.4 |
—
|
167,395 | 15.3% |
P
S
|
1,260,702 | $74,532,702 | 2015 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.84% | 1.02% |
#15
1
Prev: #14
|
0.8 |
—
|
-87,884 | -2.8% |
P
S
|
3,087,226 | $68,567,289 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMZN
AMAZON COM INC
|
Consumer Cyclical | 0.83% | 0.97% |
#16
1
Prev: #15
|
2.3 |
—
|
22,425 | 8.6% |
P
S
|
284,562 | $67,822,507 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.82% | 1.57% |
#17
6
Prev: #11
|
0.3 |
—
|
-1,828,916 | -51.3% |
P
S
|
1,736,000 | $66,888,080 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RIGL
RIGEL PHARMACEU...
|
Healthcare | 0.80% | 0.62% |
#18
8
Prev: #26
|
2.8 |
—
|
392,000 | 30.6% |
P
S
|
1,672,000 | $65,408,640 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.75% | 0.80% |
#19
1
Prev: #20
|
2.8 |
—
|
30,989 | 33.9% |
P
S
|
122,480 | $61,406,573 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRWD
IRONWOOD PHARMA...
|
Healthcare | 0.72% | 0.94% |
#20
4
Prev: #16
|
0.8 |
—
|
-1,096,000 | -7.3% |
P
S
|
13,932,000 | $58,653,720 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.70% | 0.81% |
#21
2
Prev: #19
|
0.8 |
—
|
-60,000 | -3.7% |
P
S
|
1,564,000 | $56,945,240 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.69% | 0.50% |
#22
13
Prev: #35
|
3.3 |
—
|
53,683 | 148.6% |
P
S
|
89,809 | $55,999,504 | 2017 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTCT
CALL
PTC THERAPEUTIC...
|
CALL Option | 0.66% | 0.47% |
#23
14
Prev: #37
|
3.3 |
—
|
270,000 | 69.2% |
P
S
|
660,000 | $53,836,200 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.62% | 0.74% |
#24
3
Prev: #21
|
2.7 |
—
|
146,000 | 25.3% |
P
S
|
724,000 | $50,542,440 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.57% | 0.57% |
#25
4
Prev: #29
|
2.7 |
—
|
560,000 | 47.6% |
P
S
|
1,736,000 | $46,837,280 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMVT
CALL
IMMUNOVANT INC
|
CALL Option | 0.57% | 0.84% |
#26
8
Prev: #18
|
0.2 |
—
|
-700,000 | -36.8% |
P
S
|
1,200,000 | $46,236,000 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNY
SANOFI SA
|
Healthcare | 0.56% | 0.26% |
#27
44
Prev: #71
|
3.2 |
—
|
764,000 | 254.7% |
P
S
|
1,064,000 | $45,390,240 | 2016 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.55% | 0.64% |
#28
4
Prev: #24
|
2.7 |
—
|
240,000 | 20.2% |
P
S
|
1,428,000 | $45,339,000 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GOOGL
ALPHABET INC
|
Communication Services | 0.55% | 0.61% |
#29
1
Prev: #28
|
2.2 |
—
|
7,980 | 6.7% |
P
S
|
126,494 | $45,205,161 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 0.52% | 0.41% |
#30
20
Prev: #50
|
2.7 |
—
|
1,078,000 | 33.7% |
P
S
|
4,278,000 | $42,737,220 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDB
MONGODB INC
|
Technology | 0.51% | 0.47% |
#31
7
Prev: #38
|
2.2 |
—
|
17,876 | 16.7% |
P
S
|
125,172 | $42,045,275 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.49% | 0.54% |
#32
1
Prev: #33
|
0.7 |
—
|
-58,000 | -1.6% |
P
S
|
3,678,000 | $40,347,660 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XRAY
DENTSPLY SIRONA...
|
Healthcare | 0.48% | 0.62% |
#33
8
Prev: #25
|
2.7 |
—
|
672,000 | 22.4% |
P
S
|
3,672,000 | $38,959,920 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UBER
UBER TECHNOLOGI...
|
Technology | 0.44% | 0.66% |
#34
11
Prev: #23
|
0.7 |
—
|
-20,852 | -4.0% |
P
S
|
497,908 | $35,929,041 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXGN
AXOGEN INC
|
Healthcare | 0.44% | 0.55% |
#35
4
Prev: #31
|
0.7 |
—
|
-161,000 | -17.2% |
P
S
|
775,000 | $35,797,250 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.41% | 0.61% |
#36
9
Prev: #27
|
0.7 |
—
|
-76,000 | -14.2% |
P
S
|
460,000 | $33,644,400 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GTLB
GITLAB INC
|
Technology | 0.40% | 0.40% |
#37
14
Prev: #51
|
0.7 |
—
|
45,477 | 4.4% |
P
S
|
1,074,141 | $32,793,525 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FIVN
FIVE9 INC
|
Technology | 0.40% | 0.43% |
#38
8
Prev: #46
|
0.7 |
—
|
-56,000 | -3.5% |
P
S
|
1,536,000 | $32,747,520 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUBS
HUBSPOT INC
|
Technology | 0.40% | 0.56% |
#39
9
Prev: #30
|
2.7 |
—
|
49,464 | 38.5% |
P
S
|
178,047 | $32,495,358 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.37% | 0.48% |
#40
4
Prev: #36
|
2.1 |
—
|
22,327 | 14.1% |
P
S
|
180,286 | $30,407,037 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MSFT
MICROSOFT CORP
|
Technology | 0.37% | 0.32% |
#41
21
Prev: #62
|
3.1 |
—
|
31,721 | 64.9% |
P
S
|
80,581 | $30,058,325 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OFIX
ORTHOFIX MED IN...
|
Healthcare | 0.36% | 0.55% |
#42
10
Prev: #32
|
2.6 |
—
|
564,000 | 20.9% |
P
S
|
3,264,000 | $29,832,960 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.35% | 0.44% |
#43
Prev: #43
|
0.1 |
—
|
-68,752 | -48.7% |
P
S
|
72,527 | $28,809,175 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANGO
ANGIODYNAMICS I...
|
Healthcare | 0.35% | 0.38% |
#44
10
Prev: #54
|
2.1 |
—
|
329,000 | 17.6% |
P
S
|
2,198,000 | $28,595,980 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
CALL
TRAVERE THERAPE...
|
CALL Option | 0.35% | — |
#45
Prev: #—
|
3.6 |
—
|
500,000 | — |
NEW
|
500,000 | $28,405,000 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WAT
WATERS CORP
|
Healthcare | 0.34% | — |
#46
Prev: #—
|
3.6 |
—
|
75,004 | — |
NEW
|
75,004 | $28,129,500 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
CALL
MINERALYS THERA...
|
CALL Option | 0.34% | — |
#47
Prev: #—
|
3.6 |
—
|
1,040,000 | — |
NEW
|
1,040,000 | $28,059,200 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
S
CALL
SENTINELONE INC
|
CALL Option | 0.33% | 0.38% |
#48
5
Prev: #53
|
0.6 |
—
|
-50,000 | -3.0% |
P
S
|
1,600,000 | $27,152,000 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.33% | 0.43% |
#49
4
Prev: #45
|
3.1 |
—
|
2,432,000 | 53.0% |
P
S
|
7,024,000 | $26,831,680 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.33% | 0.33% |
#50
11
Prev: #61
|
1.1 |
—
|
no change | no change |
P
S
|
2,000,000 | $26,600,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 433 holdings